Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples